Faculty of physical therapy
Giza, Giza Governorate, 1124, Egypt
NCT Number: NCT06701591
The modified radical mastectomy (MRM) is a major surgical approach that necessitates the dissection of axillary lymph nodes. As a result, there is more bleeding and the treatment takes longer time. This treatment is used to treat locally advanced breast cancer. Numerous factors, including pain and respiratory depression from general anaesthesia, can impair respiratory function during the post-operative period. Pain causes the thoracic cage's post-operative movement to be restricted and the breathing muscles to become inhibited.
Looking for future studies?
Notify Me30 year–50 year
Female
Interventional
Not applicable
Giza, Giza Governorate, 1124, Egypt
KT is a new technology that is being used in the treatment of post-surgical and respiratory problems, among other innovative evidence-based therapeutic options in patient care. Recently, this method is useful for treating a variety of sports-related and musculoskeletal disorders, as well as pain management. According to a small body of research on the usefulness and efficacy of KT in treating respiratory conditions in patients with chronic obstructive pulmonary disease (COPD), it can lead to improvements in respiratory muscle strength and pulmonary function.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be seated on a chair, KT will be applied bilaterally at the end of the expiration on the fifth to sixth and ninth to tenth intercostal muscles transversally and on the anterior and posterior axillary line longitudinally with 50% tension. In order to stimulate the muscle and support the function, the stimulation technique is usually applied from the origin to the insertion of the muscle with the recommended stretching of 25 to 50%.
The chest physical therapy program is consisted of deep breathing exercises, postural drainage, and cough.
Time frame: 4 weeks
The visual representation of the pain range that a patient thinks they might experience is called a linear scale. The score is ranged from 0 to 10. The least the score, the better results. While, the higher the score, the worst the results.
Time frame: 4 weeks
The forced vital capacity (FVC) will be measured by spirometer.
Time frame: 4 weeks
forced expiratory volume at first second (FEV1) will be measured by spirometer.
Time frame: 4 weeks
Forced expiratory volume at first second /Forced vital capacity ratio will be measured by spirometer.
Time frame: 4 weeks
Respiratory muscle strength will be measured by assessing the maximal inspiratory and maximal expiratory pressures (MIP) and maximal expiratory pressures (MEP).
Time frame: 4 weeks
Quality of life will be measured by the Short Form-36 (SF-36). It is a questionnaire with eight subscales that gives information about the health status and quality of life of the person. Scores on each subscale range from 0 to 100, with 0 corresponding to the worst health status and 100 to the best health status.
Cairo University
Other
Efficacy of Combined Kinesio-Taping With Chest Physiotherapy Program on Pain, Pulmonary Function, Respiratory Muscle Strength and Quality of Life After Mastectomy: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02976103
Mastectomy, Neurologic Manifestations
Boston, Massachusetts, United States
View Trial DetailsNCT03067922
Mastectomy, Mental Disorders
Mumbai, Maharashtra, India
View Trial DetailsNCT07680296
Breast Cancer, Breast Diseases
Pisa, Italy
View Trial DetailsNCT02894021
Cysts, Hemic and Lymphatic Diseases
Amiens, France
View Trial Details